Clinical trial
A Two-part Study; Consisting of a Pilot Part Followed by a Randomized, Parallel Group Part; Comparing Topically Applied Novel Gel Containing Lactic Acid With no Treatment on Women With Candida Vulvovaginitis
NCT05012852 is registered in ClinicalTrials.gov with PepTonic Medical AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Two-part Study; Consisting of a Pilot Part Followed by a Randomized, Parallel Group Part; Comparing Topically Applied Novel Gel Containing Lactic Acid With no Treatment on Women With Candida Vulvovaginitis
- Lead sponsor
- PepTonic Medical AB
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 30, 2021
- Completion date
- June 30, 2022
- Enrollment
- 126 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
candidal vulvovaginitis, vaginal candidiasis, vulvovaginal candidiasis